Cerebroprotection in patients with hypertension and comorbid disease
- Authors: Mamedov M.N1
-
Affiliations:
- National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
- Issue: Vol 20, No 1 (2018)
- Pages: 62-65
- Section: Articles
- URL: https://bakhtiniada.ru/2075-1753/article/view/95012
- DOI: https://doi.org/10.26442/2075-1753_2018.1.62-65
- ID: 95012
Cite item
Full Text
Abstract
The review concerns some aspects of cerebrovascular comorbidities and major vessels disease. Hypertension is one of the main reasons for cerebral stroke. For primary and secondary prevention of cerebral stroke and its late effects development, adequate treatment of hypertension is required. Cognitive impairment in elderly patients is widely discussed nowadays. Effective antihypertensive therapy with calcium antagonists, such as nitrendipine, reduces cognitive impairment and demention development, particularly, of vascular genesis.
Full Text
##article.viewOnOriginalSite##About the authors
M. N Mamedov
National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Email: mmamedov@mail.ru
д-р мед. наук, проф., рук. лаб. по разработке междисциплинарного подхода в профилактике хронических неинфекционных заболеваний отд. профилактики коморбидных состояний 101990, Russian Federation, Moscow, Petroverigskii per., d. 10, str. 3
References
- Writing Group Members, Mozaffarian D, Benjamin E.J, Go A.S. et al. American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016; 133 (4): e38-360.
- Метельская В.А., Гаврилова Н.Е., Яровая Е.А., Бойцов С.А. Интегрированный биомаркер: возможности неинвазивной диагностики коронарного атеросклероза. Рос. кардиологич. журн. 2017; 6: 132-8.
- Румянцева С.А., Оганов Р.Г., Силина Е.В. Современные концепции лечения пациентов с сосудистой коморбидностью. Кардиоваскулярная терапия и профилактика. 2012; 11 (6): 50-5
- Liakos C.I, Grassos C.A, Babalis D.K; European Society of Hypertension; European Society of Cardiology. 2013 ESH/ESC guidelines for the management of arterial hypertension: what has changed in daily clinical practice? High Blood Press Cardiovasc Prev 2015; 22 (1): 43-53.
- Ninomiya T, Ohara T, Hirakawa Y et al. Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study. Hypertension 2011; 58 (1): 22-8.
- Forette F, Seux M.L, Staessen J.A et al; Systolic Hypertension in Europe Investigators. Arch Intern Med 2002; 162 (18): 2046-52.
- Wang J.G, Staessen J.A, Gong L, Liu L. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 2000; 160: 211-20.
- Bachmeier C et al. Selective dihydropyridin compounds facilitate the clearence of amiloid across the blood-brain barrier. Eur J Pharmacology 2011; 659: 124-9.
- Peters J, Booth A, Peters R. Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review. Ther Adv Chronic Dis 2015; 6 (4): 160-9.
- Coca A. Hypertension and vascular dementia in the elderly: the potential role of anti-hypertensive agents. Curr Med Res Opin 2013; 29 (9): 1045-54.
Supplementary files
